Company news
NextCure, Inc. news in 2020
NextCure, Inc.'s news releases, calls and decks from 2020, newest first.
NextCure Provides Updates on NC318 Clinical Program
December 16, 2020
NextCure Reports Third Quarter 2020 Financial Results
November 4, 2020
NextCure Announces Appointment of John G. Houston, Ph.D., to its Board of Directors
September 13, 2020
NextCure Reports Second Quarter 2020 Financial Results
August 5, 2020
NextCure Provides an Interim Update of the Phase 2 Portion of the NC318 Monotherapy Phase 1/2 Trial and Announces Departure of Chief Medical Officer
July 12, 2020
NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors
July 6, 2020
NextCure Reports First Quarter 2020 Financial Results
May 6, 2020
NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 Pandemic
April 12, 2020
NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors
March 29, 2020
NextCure Reports Fourth Quarter and Full Year 2019 Financial Results
March 11, 2020